PLVAP and neoplasm: To determine whether PLVAP expression in tumor vascular endothelial cells could be used as a target for treating Hep3B xenograft, monoclonal MECA32 anti-PLVAP antibody was chemically cross-linked with the extracellular domain of human tissue factor (MECA32-TF).